Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.

John B Kisiel A Mark Fendrick Derek W Ebner A Burak Ozbay Vahab Vahdat Chris Estes Paul J Limburg

Published in: Journal of medical economics (2024)

Triennial screening with mt-sDNA resulted in better clinical outcomes at a lower cost compared with the modeled blood-based test even at perfect adherence, supporting application of blood-based tests only as a secondary screening option.

Keyphrases

colorectal cancer screening
type diabetes
metabolic syndrome
glycemic control
adipose tissue
weight loss